PRECIGEN, INC. — Director's Dealing 2021

May 7, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2021-04-02

Reporting Person: Osborne D. Bradford (VP, Finance and Accounting)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60380	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock (Right to Buy)	$6.85	2021-07-29	Common Stock (4008)		Direct
Option to Purchase Common Stock (Right to Buy)	$29.56	2024-03-20	Common Stock (15586)		Direct
Option to Purchase Common Stock (Right to Buy)	$45.69	2025-03-12	Common Stock (20783)		Direct
Option to Purchase Common Stock (Right to Buy)	$34.85	2026-03-10	Common Stock (15059)		Direct
Option to Purchase Common Stock (Right to Buy)	$20.94	2027-02-02	Common Stock (40000)		Direct
Option to Purchase Common Stock (Right to Buy)	$4.45	2029-05-14	Common Stock (75000)		Direct
Restricted Stock Units	$		Common Stock (4340)		Direct
Restricted Stock Units	$		Common Stock (13774)		Direct

Footnotes

F1: The stock options are fully vested.

F2: 18,750 of the stock options are fully vested. The remaining stock options vest in equal installments on each of May 14, 2021, May 14, 2022 and May 14, 2023.

F3: The restricted stock units ("RSUs") vest in full on January 2, 2022.

F4: Each RSU represents a contingent right to receive one share of Precigen Common Stock.

F5: The RSUs vest 50% on January 4, 2022 and 50% on January 4, 2023.